Clareon TruPlus Study
Key facts
- Who runs it
- Alcon Research
- Where
- Brecksville, Mt. Pleasant, Phoenix, Salt Lake City, and Sugar Land, United StatesSee the 5 sites
- Trial code
- Status
- Recruiting
- People taking part
- 185 people, planned
- Started
- 26 May 2026
- Expected to end
- Jun 2028
- Type of study
- Interventional
- Treatments tested
- Clareon TruPlus Monofocal Non-Toric IOL
- Clareon TruPlus Monofocal Toric IOL
- Phacoemulsification
- Record updated
- 30 October 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification
- Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator
- Astigmatism suitable for correction with available toric IOL models
- Other protocol-specified inclusion criteria may apply
Who cannot take part
- Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol
- Moderate to severe dry eye that would affect study measurements
- Other protocol-specified exclusion criteria may apply
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Aphakia or astigmatism
This trial is currently available in United States.
- Cleveland Eye ClinicBrecksville, United StatesTaking people
- Carolina Eyecare Physicians LLCMt. Pleasant, United StatesTaking people
- Eye Doctors of ArizonaPhoenix, United StatesTaking people
- The Eye Institute of UtahSalt Lake City, United StatesTaking people
- Berkeley Eye CenterSugar Land, United StatesTaking people
About the trial
What the trial wants to find out
The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.
The group in the trial
- Clareon TruPlus Monofocal IOLTreatment being tested
Implantation with the Clareon TruPlus Monofocal IOL (Non-Toric or Toric) following removal of the clouded natural lens using phacoemulsification
Treatment: Clareon TruPlus Monofocal Non-Toric IOL, Clareon TruPlus Monofocal Toric IOL, and Phacoemulsification
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clareon TruPlus Single-Arm Study
- Criteria questions
- Built from NCT07502456, who can take part
- Record updated
- 30 October 2026